Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a new survey that was published on Friday. The new ...

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight ...